Remnant Cholesterol Calculator

Q: How do I calculate remnant cholesterol?

Subtract both HDL cholesterol and LDL cholesterol from total cholesterol. Equivalently, subtract LDL from non-HDL cholesterol. Every value comes from a standard lipid panel, so no extra test is needed.

Q: Is there a guideline target for remnant cholesterol?

No. The figures of 20 and 30 mg/dL (about 0.5 and 0.8 mmol/L) are widely quoted from cohort studies, but no major guideline sets a remnant cholesterol threshold or target. They should be read as descriptive rather than as treatment triggers.

Q: Does remnant cholesterol cause cardiovascular disease?

Mendelian randomisation studies show that genetically raised remnant cholesterol is associated with a proportionate rise in ischaemic heart disease, which supports a causal role. It is one of the recognised contributors to residual risk in patients already at LDL target.

Q: Does the sample need to be fasting?

The result is sensitive to it. A non-fasting sample contains chylomicrons and their remnants, which raise the figure. Compare values only between samples taken in the same fasting state.

Q: Why does the LDL method matter?

The remnant figure is a subtraction, so it inherits whatever assumption the LDL carried. A Friedewald LDL already estimates VLDL cholesterol from the triglyceride, so a remnant derived from it is not comparable with one derived from a directly measured LDL.

Subtract HDL and LDL from total cholesterol to get the cholesterol carried in triglyceride-rich lipoproteins and their remnants — free from any standard lipid panel, with thresholds that are conventional rather than guideline-based.

Last updated 2 Sep 2026

Remnant Cholesterol

3 inputs → mg/dL

Total cholesterol (mg/dL)

HDL cholesterol (mg/dL)

LDL cholesterol (mg/dL)Use the calculated or directly measured LDL from the same sample.

35.0mg/dLExample

Total cholesterol 215 mg/dL, HDL 48 mg/dL, LDL 132 mg/dL

Formula

Remnant-C = total cholesterol − HDL-C − LDL-C
Equivalently: remnant-C = non-HDL-C − LDL-C

remnant-C: the cholesterol carried in VLDL, IDL, chylomicron remnants and VLDL remnants — everything atherogenic that is not LDL
non-HDL-C: total cholesterol minus HDL cholesterol; subtracting LDL from it is the same arithmetic written differently
same LDL method: the result inherits whichever LDL method was used, so a Friedewald-derived remnant and a direct-LDL-derived remnant are not comparable
mmol/L: all three terms are cholesterol, so divide the result by 38.67 to read it in mmol/L

Worked example

Total cholesterol 215 mg/dL, HDL 48 mg/dL, LDL 132 mg/dL
Non-HDL cholesterol = 215 − 48 = 167 mg/dL
167 − 132 = 35.0 mg/dL
In SI units: 35.0 ÷ 38.67 = 0.91 mmol/L
Above the conventional figure of 30 mg/dL — a convention, not a guideline threshold

The same subtraction on three panels

All values in mg/dL. Nothing here is measured that was not already on the panel — the remnant figure is arithmetic on three numbers the laboratory has already reported.
Total-C	HDL-C	LDL-C	Non-HDL-C	Remnant-C
190	60	110	130	20
215	48	132	167	35
240	38	140	202	62

Commonly quoted figures, in both units

These figures appear widely in the literature and in laboratory commentary, but they are not guideline cut-offs and no major society sets a remnant cholesterol target. Read them as descriptive.
Remnant-C (mg/dL)	Remnant-C (mmol/L)	Description commonly used
< 20	< 0.5	Optimal
20 – 29	0.5 – 0.8	Borderline
≥ 30	≥ 0.8	Elevated

Cholesterol in the triglyceride-rich particles, and why the number is method-dependent

Remnant cholesterol is the cholesterol carried in triglyceride-rich lipoproteins and their remnants: VLDL, intermediate-density lipoprotein, and the partially lipolysed chylomicron and VLDL particles left behind after lipoprotein lipase has acted. It is what remains when LDL cholesterol is taken out of non-HDL cholesterol, which is why the calculation is simply total cholesterol minus HDL minus LDL. Every one of those particles carries apolipoprotein B and is small enough to enter the arterial intima.

Its clinical interest comes from Mendelian randomisation. Genetic variants that raise remnant cholesterol raise ischaemic heart disease risk in proportion, which supports a causal role rather than an association driven by the metabolic company triglycerides keep. That evidence is one of the reasons remnant cholesterol is invoked to explain residual risk — the events that continue to occur in patients whose LDL is at target — alongside lipoprotein(a) and inflammation.

The practical attraction is that it costs nothing. Any standard lipid panel already carries the three numbers, so a remnant figure can be derived retrospectively from historical results without a further sample or a further assay. That also sets its limit: it adds no measurement, and it inherits every weakness of the values it is built from.

Two of those weaknesses matter. The figure is sensitive to the fasting state, because chylomicrons and their remnants in a non-fasting sample add cholesterol that a fasting sample would not contain. It is also sensitive to which LDL method was used: a remnant derived from a Friedewald LDL and one derived from a direct LDL on the same sample are not comparable, since the Friedewald result already contains an assumption about VLDL cholesterol that the subtraction then partly reverses. Compare remnant values only across samples collected and analysed the same way, and treat the 20 and 30 mg/dL figures in circulation as conventions from cohort studies rather than as guideline thresholds.

Frequently asked questions

How do I calculate remnant cholesterol?

Subtract both HDL cholesterol and LDL cholesterol from total cholesterol. Equivalently, subtract LDL from non-HDL cholesterol. Every value comes from a standard lipid panel, so no extra test is needed.

Is there a guideline target for remnant cholesterol?

No. The figures of 20 and 30 mg/dL (about 0.5 and 0.8 mmol/L) are widely quoted from cohort studies, but no major guideline sets a remnant cholesterol threshold or target. They should be read as descriptive rather than as treatment triggers.

Does remnant cholesterol cause cardiovascular disease?

Mendelian randomisation studies show that genetically raised remnant cholesterol is associated with a proportionate rise in ischaemic heart disease, which supports a causal role. It is one of the recognised contributors to residual risk in patients already at LDL target.

Does the sample need to be fasting?

The result is sensitive to it. A non-fasting sample contains chylomicrons and their remnants, which raise the figure. Compare values only between samples taken in the same fasting state.

Why does the LDL method matter?

The remnant figure is a subtraction, so it inherits whatever assumption the LDL carried. A Friedewald LDL already estimates VLDL cholesterol from the triglyceride, so a remnant derived from it is not comparable with one derived from a directly measured LDL.

Related calculators

References

Varbo A, Benn M, Tybjærg-Hansen A, Jørgensen AB, Frikke-Schmidt R, Nordestgaard BG. Remnant cholesterol as a causal risk factor for ischemic heart disease. J Am Coll Cardiol. 2013;61(4):427–436.
Nordestgaard BG, Varbo A. Triglycerides and cardiovascular disease. Lancet. 2014;384(9943):626–635.
Grundy SM, Stone NJ, Bailey AL, et al. 2018 AHA/ACC multisociety guideline on the management of blood cholesterol. Circulation. 2019;139(25):e1082–e1143.

Medical Disclaimer: The tools and content provided here are for educational and reference purposes only. They are not intended to substitute for professional medical advice, diagnosis, or treatment. Clinical decisions should always be based on the comprehensive assessment of a qualified healthcare professional.